Delivery Order SPE2DB22D3501-SPE2DB24FWM32

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, to Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $1,182.50, is a Firm Fixed Price Delivery Order that provides the 4565219963 QSYMIA 3.75 MG-23 MG CAPSULE 30S medical supply. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides Qsymia 7.5 mg-46 mg capsules to the Defense Logistics Agency (DLA). The $1,245.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products...
This federal contract award, valued at $1,887.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QSYMIA 7.5 MG-46 MG capsules, with a performance period extending through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $35,354.12 firm-fixed-price delivery order is for the supply of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and medical equipment. The contract has an ultimate completion date of August 20, 2024 and was awarded on August 19, 2022. Amerisourcebergen, a major pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.40, is for the delivery of the prescription medication Qsymia 3.75 mg-23 mg capsules. The contract is a firm fixed-price delivery order, with a performance period ending on May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This federal contract award, valued at $29,842.50, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of pharmaceutical and medical supplies, including a wide range of prescription medications, over-the-counter drugs, and specialty medical commodities. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to support...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $6,946.54 firm-fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies to support the agency's overall healthcare operations. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen, through its Corporate Office division, has been...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,875.04 firm-fixed-price delivery order, awarded on July 31, 2024, is for the supply of various pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies and equipment. The contract has a completion date of August 1, 2024 and does not have a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $7,519.74 firm fixed-price delivery order is for the supply of pharmaceutical products and medical supplies to support government healthcare programs. It has an ultimate completion date of August 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWM32
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Qsymia. The $3,501.18 Firm Fixed Price delivery order contract has an ultimate completion date of August 2, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs. The company holds several large Indefinite Delivery Contracts with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to deliver a comprehensive selection of essential medical commodities. This specific contract award does not utilize a set-aside designation.

Generated 10/31/24, 9:30 AM